middle.news
Resonance Health Completes $13.8M Trial Recruitment with FY26 Positive Cash Flow
9:54am on Friday 24th of July, 2026 AEST
•
Healthcare
Read Story
Resonance Health Completes $13.8M Trial Recruitment with FY26 Positive Cash Flow
9:54am on Friday 24th of July, 2026 AEST
Key Points
FY26 net operating cash inflow of $2.9 million
Major $13.8 million clinical trial recruitment completed
SaMD forward orders and tender pipeline exceed $12 million
TrialsWest clinics profitable and expanding
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Resonance Health (ASX:RHT)
OPEN ARTICLE